Development of <sup>18</sup>F-Labeled Acridone Analogue for Tumor Imaging via Stimulator of Interferon Genes Targeting-Reference-Cited by-同舟云学术

Development of ¹⁸F-Labeled Acridone Analogue for Tumor Imaging via Stimulator of Interferon Genes Targeting

Published:2023-05-27 Issue:7 Volume:20 Page:3529-3538
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Liu Huanhuan¹,Sun Yuan¹,Li Jindian¹,Chen Yingxi¹,Liu Jia¹,Fang Jianyang¹,Yang Hongzhang¹,Feng Lixia¹,Peng Shilan¹,Zhuang Rongqiang¹,Guo Zhide¹,Zhang Xianzhong²³^ORCID

Affiliation:

1. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China

2. Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

3. Institute of Clinical Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funder

National Natural Science Foundation of China

National High-Level Hospital Clinical Research Funding

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00137

Reference51 articles.

1. Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy